Plotkin's Vaccines, 7th Edition
- Includes complete information for each disease, including clinical characteristics, microbiology, pathogenesis, diagnosis, and treatment, epidemiology, and public health and regulatory issues - plus complete information for each vaccine, including its stability, immunogenicity, efficacy, duration of immunity, adverse events, indications, contraindications, precautions, administration with other vaccines, and disease-control strategies.
- Analyzes the cost-benefit and cost-effectiveness of different vaccine options.
- Helps you clearly visualize concepts and objective data through an abundance of tables and figures.
From the development of each vaccine to its use in reducing disease, Plotkin's Vaccines, 7th Edition, provides the expert information you need to provide optimal care to your patients. This award-winning text offers a complete understanding of each disease, as well as the latest knowledge of both existing vaccines and those currently in research and development. Described by Bill Gates as "an indispensable guide to the enhancement of the well-being of our world," Plotkin's Vaccines is a must-have reference for current, authoritative information in this fast-moving field.
特徴
- Includes complete information for each disease, including clinical characteristics, microbiology, pathogenesis, diagnosis, and treatment, epidemiology, and public health and regulatory issues - plus complete information for each vaccine, including its stability, immunogenicity, efficacy, duration of immunity, adverse events, indications, contraindications, precautions, administration with other vaccines, and disease-control strategies.
- Analyzes the cost-benefit and cost-effectiveness of different vaccine options.
- Helps you clearly visualize concepts and objective data through an abundance of tables and figures.
| ISBN | 9780323357616 |
|---|---|
| Author Information | By Stanley A. Plotkin, MD, Emeritus Professor of Pediatrics, University of Pennsylvania, Emeritus Professor, Wistar Institute, Former Chief, Division of Infectious Diseases, The Children's Hospital of Philadelphia, Philadelphia, PA; Former Medical and Scientific Director, Pasteur Merieux Connaught (now Sanofi Pasteur), Marnes-la-Coquette, France; Walter Orenstein, MD, DSc (HON), Professor of Medicine and Pediatrics, and Global Health, Emory University; Associate Director, Emory Vaccine Center, Atlanta GA; Bill & Melinda Gates Foundation, Seattle, WA; Former Director, National Immunization Program, Centers for Disease Control and Prevention, Atlanta GA ; Paul A. Offit, MD, Chief, Division of Infectious Diseases, Director, Vaccine Education Center, The Childrne's Hospital of Philadelphia; Professor of Pediatrics, Maurice R. Hilleman Professor of Vaccinology, Perelman School of Medicine, The University of Pennsylvania School of Medicine, Philadelphia, PA. and Kathryn M. Edwards, MD, Sarah H. Sell and Cornelius Vanderbilt Chair in Pediatrics Professor of Pediatrics, Vanderbilt University School of Medicine. |
| Published Reviews | Doody's Core Titles® 2022 2018 BMA Awards: Winner, Public Health |
| Table of Content | Section 1: General Aspects of Vaccination 1. A Short History of Vaccination 2. Vaccine Immunology 3. Correlates of Protection 4. The Vaccine Industry 5. Vaccine Manufacturing 6. Evolution of Adjuvants Across the Centuries 7. Vaccine Additives and Manufacturing Residuals in Vaccines Licensed in the United States 8. Passive Immunization 9. General Immunization Practices Section 2: Licensed Vaccines and Vaccines in Development 10. Adenovirus Vaccines 11. Anthrax Vaccines 12. Biodefense and Special Pathogen Vaccines 13. Cancer Vaccines 14. Cholera Vaccines 15. Combination Vaccines 16. Cytomegalovirus Vaccines 17. Dengue Vaccines 18. Diarrhea Caused by Bacteria 19. Diphtheria Toxoid 20. Ebola Vaccines 21. Enterovirus 71 22. Epstein-Barr Virus Vaccines 23. Haemophilus influenzae Type b Vaccines 24. Hepatitis A Vaccines 25. Hepatitis B Vaccines 26. Hepatitis C Vaccines 27. Hepatitis E Vaccines 28. Herpes Simplex Virus Vaccines 29. Human Immunodeficiency Virus Vaccines 30. Human Papillomavirus Vaccines 31. Inactivated Influenza Vaccines 32. Influenza Vaccine-Live 33. Japanese Encephalitis Vaccines 34. Lyme Disease Vaccines 35. Malaria Vaccines 36. Maternal Immunization 37. Measles Vaccines 38. Meningococcal Capsular Group A, C, W, and Y Conjugate Vaccines 39. Meningococcal Capsular Group B Vaccines 40. Mumps Vaccines 41. Noninfectious Disease Vaccines 42. Norovirus Vaccines 43. Parasitic Disease Vaccines 44. Pertussis Vaccines 45. Plague Vaccines 46. Pneumococcal Conjugate Vaccine and Pneumococcal Common Protein Vaccines 47. Pneumococcal Polysaccharide Vaccines 48. Poliovirus Vaccine-Inactivated 49. Poliovirus Vaccine-Live 50. Rabies Vaccines 51. Respiratory Syncytial Virus Vaccines 52. Rotavirus Vaccines 53. Rubella Vaccines 54. Smallpox and Vaccinia 55. Staphylococcus aureus Vaccines 56. Streptococcus Group A Vaccines 57. Streptococcus Group B Vaccines 58. Tetanus Toxoid 59. Tickborne Encephalitis Vaccines 60. Tuberculosis Vaccines 61. Typhoid Fever Vaccines 62. Varicella Vaccines 63. Yellow Fever Vaccines 64. Zika Virus 65. Zoster Vaccines Section 3: New Technologies 66. Technologies for Making New Vaccines 67. Development of Gene-Based Vectors for Immunization 68. Technologies to Improve Immunization Section 4: Vaccination of Special Groups 69. Vaccination of Immunocompromised Hosts 70. Vaccination of Human Immunodeficiency Virus-Infected Persons 71. Vaccines for International Travel 72. Vaccines for Healthcare Personnel Section 5: Public Health and Regulatory Issues 73. Immunization in the United States 74. Immunization in Europe 75. Immunization in the Asia-Pacific Region 76. Immunization in Developing Countries 77. Community Protection 78. Economic Analyses of Vaccine Policies 79. Regulation and Testing of Vaccines 80. Regulation of Vaccines in Europe 81. Regulation of Vaccines in Low- and Middle-Income Countries 82. Vaccine Safety 83. Legal Issues 84. Ethics Appendix: Websites and Applications for Mobile Devices with Information about Immunization |
| 発行日 | 06-06-2017 |
| Pages | 1698 |
| trim | 276 x 216 (8 1/2 x 10 7/8) |
| 在庫状況 | In Stock |
| deltacomm1code | Books |
